Antagonism of LPS and IFN-γ Induction of iNOS in Human Saphenous Vein Endothelium by Morphine and Anandamide by Nitric Oxide Inhibition of Adenylate Cyclase
Authors:
- George B. StefanoGSGeorge B. Stefano
- Michel SalzetMSMichel Salzet
- Harold I. MagazineHMHarold I. Magazine
- Thomas V. BilfingerTBThomas V. Bilfinger
- 1 June 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 31 (6) , 813-820
Abstract
Nitric oxide (NO) production regulates vasodilation in many blood vessels. Additionally, constitutive NO release is being associated with positive biomedical phenomena, whereas inducible NO synthase (iNOS)-associated NO release with detrimental consequences in regard to endothelial inflammatory activities. As yet, an important link demonstrating why one is activated over the other is not available. Previous studies have demonstrated that morphine and anandamide effector processes are coupled to NO release in human endothelial cells (ECs). This study now extends this observation in that these endogenous signaling molecules may use NO directly to inhibit adenylate cyclase activity. Activation of human ECs, obtained from the saphenous vein, with morphineor anandamide-stimulated NO release (35 nM and 28 nM, respectively) that peaked within 5 min and returned to basal levels within 10 min of agonist stimulation, consistent with constitutive NO synthase (cNOS) activation. Significant release of NO from ECs stimulated with lipopolysaccharide (LPS) and interferon-γ (IFN-γ) occurred after 2 h after exposure and remained significantly increased over basal levels for 24-48 h (28 nM), consistent with iNOS activation. Preincubation of ECs with morphine or anandamide before, but not after, the addition of LPS + IFN, blocked iNOS activity. Exposure of ECs to the NO donor, SNAP, before the addition of LPS + IFN, blocked iNOS induction, whereas preincubation of ECs with inhibitors of NOS, before morphine or anandamide exposure, restored LPS + IFN induction of iNOS, suggesting a direct impact of NO on the regulation of iNOS activity. Morphine and anandamide stimulation of ECs did not stimulate cyclic adenosine monophosphate (cAMP) accumulation, whereas a marked increase in cAMP was observed in ECs treated with LPS + IFN (8.2 to 33 pmol/mg protein). Treatment of ECs with LPS + IFN did not induce cAMP accumulation in ECs treated with morphine, anandamide, or SNAP before LPS + IFN exposure. These data suggest that cAMP is required for the induction of iNOS in ECs and that NO may directly impair adenylate cyclase activity, preventing iNOS activation.Keywords
This publication has 29 references indexed in Scilit:
- Opioid and Opiate Immunoregulatory ProcessesCritical Reviews in Immunology, 1996
- Presence of the μ3 Opiate Receptor in Endothelial CellsJournal of Biological Chemistry, 1995
- Constitutive nitric oxide release is impaired after ischemia and reperfusionThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Morphine affects cytostatic activity of macrophages by the modulation of nitric oxide releaseInternational Journal of Immunopharmacology, 1995
- Opioids Inhibit the Induction of Nitric Oxide Synthase in J774 MacrophagesBiochemical and Biophysical Research Communications, 1995
- Chronic Morphine Treatment Suppresses CTL-Mediated Cytolysis, Granulation, and cAMP Responses to AlloantigenBrain, Behavior, and Immunity, 1994
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Endothelial and Myocardial Cell Protection by a Cysteine-Containing Nitric Oxide Donor After Myocardial Ischemia and ReperfusionJournal of Cardiovascular Pharmacology, 1993
- Inhibition of adenylate cyclase by Δ9-Tetrahydrocannabinol in mouse spleen cells: A potential mechanism for cannabinoid- mediated immunosuppressionLife Sciences, 1992
- Effects of chronic exposure of NG108-15 cells to morphine or ethanol on binding of nuclear factors to cAMP-response elementBiochemical and Biophysical Research Communications, 1991